Source:http://linkedlifedata.com/resource/pubmed/id/20463006
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-7-19
|
pubmed:abstractText |
We investigated the signaling pathways associated with microtubule interaction and apoptosis in U937 cells in vitro and in the U937 xenograft model in vivo by using 6-pyrrolidinyl-2-(2-hydroxyphenyl)-4-quinazolinone (MJ-29). MJ-29 induced growth inhibition and cell death of leukemia cell lines (U937, HL-60, K562, and KG-1) in a dose- and time-dependent manner but did not obviously impair the viability of normal cells (peripheral blood mononuclear cells and human umbilical vein endothelial cells). MJ-29 interacted with alpha- and beta-tubulin, inhibited tubulin polymerization both in vitro and in vivo, and disrupted microtubule organization. MJ-29 caused mitotic arrest by activating cyclin-dependent kinase 1 (CDK1)/cyclin B complex activity. MJ-29-induced growth inhibition and activation of CDK1 activity were significantly attenuated by roscovitine (CDK inhibitor) and CDK1 small interfering RNA (siRNA). Furthermore, MJ-29-induced Bcl-2 phosphorylation was also significantly attenuated by CDK1 siRNA. MJ-29 caused an increase in the protein levels of cytosolic cytochrome c, apoptotic protease-activating factor-1, procaspase-9, and apoptosis-inducing factor. MJ-29-promoted activation of caspase-9 and caspase-3 during apoptosis was significantly attenuated by caspase-9 and caspase-3 inhibitors. It is noteworthy that in BALB/c(nu/nu) mice bearing U937 xenograft tumors MJ-29 inhibited tumor growth in vivo. The terminal deoxynucleotidyl transferase-mediated d-UTP nick end-labeling-positive apoptotic cells of tumor sections significantly increased in MJ-29-treated mice compared with the control group. In conclusion, our results suggest that MJ-29 induces mitotic arrest and apoptosis in U937 cells via CDK1-mediated Bcl-2 phosphorylation and inhibits the in vivo tumor growth of U937 xenograft mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biopolymers,
http://linkedlifedata.com/resource/pubmed/chemical/CDC2 Protein Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin,
http://linkedlifedata.com/resource/pubmed/chemical/Tubulin Modulators
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1521-0103
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
334
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
477-88
|
pubmed:meshHeading |
pubmed-meshheading:20463006-Animals,
pubmed-meshheading:20463006-Antineoplastic Agents,
pubmed-meshheading:20463006-Apoptosis,
pubmed-meshheading:20463006-Biopolymers,
pubmed-meshheading:20463006-CDC2 Protein Kinase,
pubmed-meshheading:20463006-Caspase 3,
pubmed-meshheading:20463006-Caspase 9,
pubmed-meshheading:20463006-Enzyme Induction,
pubmed-meshheading:20463006-Humans,
pubmed-meshheading:20463006-Male,
pubmed-meshheading:20463006-Membrane Potential, Mitochondrial,
pubmed-meshheading:20463006-Mice,
pubmed-meshheading:20463006-Mice, Inbred BALB C,
pubmed-meshheading:20463006-Mice, Nude,
pubmed-meshheading:20463006-Mitosis,
pubmed-meshheading:20463006-Neoplasm Transplantation,
pubmed-meshheading:20463006-Phosphorylation,
pubmed-meshheading:20463006-Pilot Projects,
pubmed-meshheading:20463006-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:20463006-Signal Transduction,
pubmed-meshheading:20463006-Transplantation, Heterologous,
pubmed-meshheading:20463006-Tubulin,
pubmed-meshheading:20463006-Tubulin Modulators,
pubmed-meshheading:20463006-U937 Cells
|
pubmed:year |
2010
|
pubmed:articleTitle |
MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells.
|
pubmed:affiliation |
Department of Pharmacology, China Medical University, Taichung, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|